|
|
|
|
|
|
|
|
|
|
|
|
|
20.08.25 - 19:51
|
Medtronic Has Potential To Pursue Further Divestitures: Analyst (Benzinga)
|
|
|
Medtronic posted better-than-expected earnings, lifted its sales forecast, and faces analyst debate on growth prospects and possible divestitures.
Latest Ratings for MDT
DateFirmActionFromTo Feb 2022Credit SuisseMaintainsOutperform Feb 2022NeedhamMaintainsBuy Feb 2022Raymond JamesMaintainsOutperform
View More Analyst Ratings for MDT
View the Latest Analyst Ratings
read more...
|
|
|
20.08.25 - 16:42
|
Housing Market Cracks Widen: Top Siding Company Suffers Worst Stock Collapse In 50 Years (ZeroHedge)
|
|
|
Housing Market Cracks Widen: Top Siding Company Suffers Worst Stock Collapse In 50 Years
James Hardie Industries - the world's largest producer of fiber cement products, headquartered in Ireland and dual-listed in Sydney and New York - issued a grim housing outlook that sent its Sydney shares plunging the most in 50 years. The warning underscores deepening cracks emerging in the U.S. housing market under the continued weight of elevated interest rates. President Trump issued a new warning overnight about those rates "hurting" the housing industry.
James Hardie generates about 70% of its revenue from North America. Its flagship product, HardiePlank, is widely used in residential housing as an alternative to wood or vinyl siding. That makes the company's earnings reports closely watched, given its heavy exposure to the U.S. housing market.
Its first-quarter results missed Wall Street expectations, highlighting ongoing uncertainty in the housing market. Quarterly profit dropped to...
|
|
|
|
|
20.08.25 - 15:45
|
MALIBU® PARTNERS WITH DOLE® FOR NEW READY-TO-DRINK COCKTAILS (PR Newswire)
|
|
|
Malibu's tropical flavor meets Dole's pineapple expertise in our juiciest collab ever NEW YORK, Aug. 20, 2025 /PRNewswire/ -- Malibu has partnered with Dole to introduce Malibu & Dole Ready-to-Drink Cocktails – a new Ready-to-Drink line with Dole® coming early 2026. Inspired by the......
|
|
|
|
|
|
|
20.08.25 - 14:36
|
Santhera signs deal with Uniphar for GCC distribution of Agamree (PBR)
|
|
|
The therapy is intended for the treatment of Duchenne muscular dystrophy (DMD) in patients aged four years and above. Sales are projected to begin on a named patient
The post Santhera signs deal with Uniphar for GCC distribution of Agamree appeared first on Pharmaceutical Business review....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
